Navigation Links
Chemo Alone Effective in Treating Kids' Brain Tumors
Date:10/10/2008

Delaying, avoiding radiation could lessen long-term side effects, study finds

FRIDAY, Oct. 10 (HealthDay News) -- Using chemotherapy alone, and delaying or avoiding radiation altogether, may be effective in treating children with inoperable or progressive low-grade glioma brain tumors, according to a multi-institutional study.

Low-grade glioma is the most common brain tumor in children. If surgery can be performed, the survival rate for patients is 95 percent. But prognosis is worse for children with tumors in locations that prevent surgical removal or with tumors that progress after surgery, according to background information in a news release about the study from the University of Texas M.D. Anderson Cancer Center in Houston.

Radiation is often used to treat children with inoperable or progressive low-grade gliomas. While radiation is often effective in treating these brain tumors, it can cause long-term effects such as mental impairment, hormonal deficiencies and increased risk of stroke later in life.

This new phase III study compared two different chemotherapy regimens, and confirmed that chemotherapy can be used to control inoperable or progressive low-grade gliomas in children, said principal investigator Dr. Joann Ater, a professor of pediatrics at the Children's Cancer Hospital at M.D. Anderson.

The study of 401 patients found that a regimen of thioguanine, procarbazine, lomustine and vincristine (TPCV) was more effective than a carboplatin and vincristine (VC) regimen and achieved a 5-year, event-free survival rate of almost 50 percent.

Patients aged 5 to 10 on the TPCV regimen averaged more than eight years without disease progression, compared to an average of 5.3 years among those who received the VC regimen. Patients younger than 5 on the VC regimen averaged 2.2 years before disease progression.

The study also found that chemotherapy was most effective among neurofibromatosis patients with low-grade gliomas.

"If we can delay radiation, then we allow more time for our youngest patients to develop physically, which could decrease some of the long-term effects from [radiation] treatment," Ater said. "This trial at least gives parents more information and alternative options when making decisions about their child's treatment."

The study was presented this week at the International Society of Pediatric Oncology annual meeting, in Berlin.

More information

The American Cancer Society has more about brain and spinal cord tumors in children.



-- Robert Preidt



SOURCE: M.D. Anderson Cancer Center, news release, Oct. 6, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pneumatosis cystoids intestinalis after fluorouracil chemotherapy
2. Anti-angiogenic drugs impede chemotherapy-stimulated tumor recovery
3. Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
4. CSHL scientists correlate enzyme expression levels with chemotherapy drug response
5. Medicare Modernization Act not associated with major changes in access to chemotherapy
6. Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer
7. Solid tumor cells not killed by radiation and chemotherapy become stronger
8. Avastin Added to Chemo Helps Women With Advanced Breast Cancer
9. Erbitux Plus Chemo Improves Lung Cancer Outcomes
10. Avastin Added to Chemo Helps Women With Advanced Cancer
11. Chemo May Limit Fertility in Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: